Michael Wassil, Chairman & CEO
Mr. Wassil has over 25 years of management experience in Pharmaceuticals, Medical Devices and Biotech. Mr. Wassil has broad experience with the development of early stage companies and has raised over $150 million in public and private financing. In addition, he has managed two initial public offerings in the biotech and medical devices.
Mark Stearns, Ph.D., President and CSO
Mr. Stearns has over 20 years of research experience primarily on cancer research. Dr. Stearns has spent the last fifteen years focusing on prostate cancer research and has been the recipient of over $20 million in NIH/NCI grants. He has prior appointments at Fox Chase Cancer Institute and Georgetown University. He has 187 peer-reviewed papers and over 150 meeting abstracts.
Youji Yu, Ph.D., Vice President Research
Dr. Youji Yu has over 20 years of research experience in cancer research.He is one of the company's founders and has been working for the company for the past 5 years. Prior appointments include Fox Chase Cancer Center,Thomas Jefferson University, and Cornell University.
Min Wang, Ph.D., Director of Research
Dr. Min Wang has spent over 20 years in research and she is one of the company's founders, and has been working for the company for the past 5 years. Her prior appointments include Fox Chase Cancer Center.